Earl R. Kern - Search Results

Year	Number of Results
2002	7
2003	11
2004	11
2005	20
2006	22
2007	9
2008	8
2009	5
2010	4
2011	4
2012	2
2022	0

1

Orthopoxvirus targets for the development of new antiviral agents.

Prichard MN, Kern ER. Prichard MN, et al. Among authors: kern er. Antiviral Res. 2012 May;94(2):111-25. doi: 10.1016/j.antiviral.2012.02.012. Epub 2012 Mar 8. Antiviral Res. 2012. PMID: 22406470 Free PMC article. Review.

2

The search for new therapies for human cytomegalovirus infections.

Prichard MN, Kern ER. Prichard MN, et al. Among authors: kern er. Virus Res. 2011 May;157(2):212-21. doi: 10.1016/j.virusres.2010.11.004. Epub 2010 Nov 21. Virus Res. 2011. PMID: 21095209 Free PMC article. Review.

3

Orthopoxvirus targets for the development of antiviral therapies.

Prichard MN, Kern ER. Prichard MN, et al. Among authors: kern er. Curr Drug Targets Infect Disord. 2005 Mar;5(1):17-28. doi: 10.2174/1568005053174627. Curr Drug Targets Infect Disord. 2005. PMID: 15777195 Free PMC article. Review.

4

In vitro activity of potential anti-poxvirus agents.

Kern ER. Kern ER. Antiviral Res. 2003 Jan;57(1-2):35-40. doi: 10.1016/s0166-3542(02)00198-5. Antiviral Res. 2003. PMID: 12615301 Review.

5

National Institutes of Health consensus development conference statement: management of hepatitis B.

Sorrell MF, Belongia EA, Costa J, Gareen IF, Grem JL, Inadomi JM, Kern ER, McHugh JA, Petersen GM, Rein MF, Strader DB, Trotter HT. Sorrell MF, et al. Among authors: kern er. Hepatology. 2009 May;49(5 Suppl):S4-S12. doi: 10.1002/hep.22946. Hepatology. 2009. PMID: 19399804 No abstract available.

6

National Institutes of Health Consensus Development Conference Statement: management of hepatitis B.

Sorrell MF, Belongia EA, Costa J, Gareen IF, Grem JL, Inadomi JM, Kern ER, McHugh JA, Petersen GM, Rein MF, Strader DB, Trotter HT. Sorrell MF, et al. Among authors: kern er. Ann Intern Med. 2009 Jan 20;150(2):104-10. doi: 10.7326/0003-4819-150-2-200901200-00100. Epub 2009 Jan 5. Ann Intern Med. 2009. PMID: 19124811 Free article. No abstract available.

7

Pivotal role of animal models in the development of new therapies for cytomegalovirus infections.

Kern ER. Kern ER. Antiviral Res. 2006 Sep;71(2-3):164-71. doi: 10.1016/j.antiviral.2006.05.018. Epub 2006 Jun 19. Antiviral Res. 2006. PMID: 16828175 Review.

8

Benzimidazole analogs inhibit human herpesvirus 6.

Prichard MN, Frederick SL, Daily S, Borysko KZ, Townsend LB, Drach JC, Kern ER. Prichard MN, et al. Among authors: kern er. Antimicrob Agents Chemother. 2011 May;55(5):2442-5. doi: 10.1128/AAC.01523-10. Epub 2011 Feb 7. Antimicrob Agents Chemother. 2011. PMID: 21300829 Free PMC article.

9

N-(3,3a,4,4a,5,5a,6,6a-Octahydro-1,3-dioxo-4,6- ethenocycloprop[f]isoindol-2-(1H)-yl)carboxamides: Identification of novel orthopoxvirus egress inhibitors.

Bailey TR, Rippin SR, Opsitnick E, Burns CJ, Pevear DC, Collett MS, Rhodes G, Tohan S, Huggins JW, Baker RO, Kern ER, Keith KA, Dai D, Yang G, Hruby D, Jordan R. Bailey TR, et al. Among authors: kern er. J Med Chem. 2007 Apr 5;50(7):1442-4. doi: 10.1021/jm061484y. Epub 2007 Mar 3. J Med Chem. 2007. PMID: 17335190 Free PMC article.

10

Combinatorial optimization of isatin-beta-thiosemicarbazones as anti-poxvirus agents.

Pirrung MC, Pansare SV, Sarma KD, Keith KA, Kern ER. Pirrung MC, et al. Among authors: kern er. J Med Chem. 2005 Apr 21;48(8):3045-50. doi: 10.1021/jm049147h. J Med Chem. 2005. PMID: 15828843

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results